63rd ASH Annual Meeting & Exposition – a Postscript

The 63rd Annual Meeting & Exposition of the American Society of Hematology was held on December 11-14 – this year as a hybrid event for the first time. The MLL team attended virtually with a total of 13 contributions.

“The ASH Annual Meeting is an absolute highlight
for us every year. This is where the latest findings from our basic and
clinical research are presented. After the congress, we sit down and
discuss what adjustments we need to make to our diagnostic offers and to
the interpretation of our findings based on the data presented. It is
also exciting to see what kind of reactions we get to the data
presented, all of which greatly encourages future scientific projects
and collaborations,” said Prof. Dr. med. Claudia Haferlach, MLL founder
and managing director.

The main topics were the
continuous improvement of today’s gold standard and the diagnostics of
tomorrow, including the use of artificial intelligence (AI) in the
clinical routine and research, along with genome-wide methods of WGS
(whole genome sequencing) and WTS (whole transcriptome sequencing). We
have summarized for you all of this year’s ASH presentations with MLL

Interested in more of MLL's contributions and topic highlights at the ASH Conference? Click here to read the <!--[if gte mso 9]>

follow-up report of the ASH Annual Meeting 2020. All information about the American Society of Hematology can be found here.

The author

»Do you have questions regarding this article or do you need further information? Please send me an e-mail.«

Dr. rer. nat. Ines Schmidts

Medical Writer